Effectiveness and safety of a single-tablet regimen of emtricitabine/efavirenz/tenofovir in HIV-1-infected patients in infectious diseases department

被引:0
|
作者
Xerinda, S. [1 ]
Neves, N. [1 ]
Santos, S. [1 ]
Pineiro, C. [1 ]
Poinhos, R. [2 ]
Soares, J. [1 ]
Serrao, R. [1 ]
Sarmento, A. [1 ]
机构
[1] Ctr Hosp Sao Joao, Dept Infect Dis, Oporto, Portugal
[2] Univ Porto, Fac Ciencias Nutr & Alimentacao, P-4100 Oporto, Portugal
关键词
D O I
10.7448/IAS.15.6.18383
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:168 / 169
页数:2
相关论文
共 50 条
  • [31] Emtricitabine/rilpivirine/tenofovir disoproxil fumarate single-tablet regimen in HIV-1 infection: a guide to its use in the EU
    Deeks E.D.
    Drugs & Therapy Perspectives, 2015, 31 (8) : 251 - 258
  • [32] Intensification of a triple-nucleoside regimen with tenofovir or efavirenz in HIV-1-infected patients with virological suppression
    Gulick, Roy M.
    Lalama, Christina M.
    Ribaudo, Heather J.
    Shikuma, Cecilia M.
    Schackman, Bruce R.
    Schouten, Jeffrey
    Squires, Kathleen E.
    Koletar, Susan L.
    Pilcher, Christopher D.
    Reichman, Richard C.
    Klingman, Karin L.
    Kuritzkes, Daniel R.
    AIDS, 2007, 21 (07) : 813 - 823
  • [33] Efficacy of single-tablet darunavir, cobicistat, emtricitabine, and tenofovir alafenamide in the treatment of HIV-1
    Negredo, Eugenia
    Clotet, Bonaventura
    EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (08) : 929 - 934
  • [34] Rilpivirine, emtricitabine and tenofovir alafenamide: single-tablet combination for the treatment of HIV-1 infection in selected patients
    Ogbuagu, Onyema
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2016, 14 (12) : 1113 - 1126
  • [35] Effectiveness and safety of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate single-tablet combination among HIV-infected patients in Turkey: results from a real world setting
    Mete, Bilgul
    Gunduz, Alper
    Karaosmanoglu, Hayat Kumbasar
    Gumuser, Fatma
    Bolukcu, Sibel
    Yildiz, Dilek Sevgi
    Aydin, Ozlem Altuntas
    Bilge, Bilgenur
    Dokmetas, Ilyas
    Tabak, Fehmi
    AFRICAN HEALTH SCIENCES, 2021, 21 (04) : 1593 - 1602
  • [36] High Prevalence of Doravirine Resistance in HIV-1-Infected Patients with Virological Failure to an NNRTI-Based Single-Tablet Regimen
    Tsai, Hung-Chin
    Chen, I-Tzu
    Chang, Hui-Min
    Lee, Susan Shin-Jung
    Chen, Yao-Shen
    INFECTION AND DRUG RESISTANCE, 2022, 15 : 3857 - 3869
  • [37] Hepatic Safety of Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate Fixed-Dose Single-Tablet Regimen in HIV-Infected Patients with Active Hepatitis C Virus Infection: The hEPAtic Study
    Neukam, Karin
    Espinosa, Nuria
    Collado, Antonio
    Delgado-Fernandez, Marcial
    Jimenez-Aguilar, Patricia
    Rivero-Juarez, Antonio
    Hontanon-Antonana, Victor
    Gomez-Berrocal, Ana
    Ruiz-Morales, Josefa
    Merino, Dolores
    Carrero, Ana
    Tellez, Francisco
    Jose Rios, Maria
    Hernandez-Quero, Jose
    de Lagarde-Sebastian, Maria
    Perez-Camacho, Ines
    Vera-Mendez, Francisco
    Macias, Juan
    Pineda, Juan A.
    PLOS ONE, 2016, 11 (05):
  • [38] Patient-reported outcomes in the single-tablet regimen (STaR) trial of rilpivirine/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate in antiretroviral treatment-naive adults infected with HIV-1 through 48 weeks of treatment
    Wilkins, Ed L.
    Cohen, Calvin J.
    Trottier, Benoit
    Esser, Stefan
    Smith, Don E.
    Haas, Bernhard
    Brinson, Cynthia
    Garner, Will
    Chuck, Susan
    Thorpe, David
    De-Oertel, Shampa
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2016, 28 (03): : 401 - 408
  • [39] Single-tablet regimen is associated with reduced efavirenz withdrawal in antiretroviral na ve or switching for simplification HIV-infected patients
    Fabbiani, M.
    Grima, P.
    Prosperi, M.
    Fanti, I
    Colafigli, M.
    Zaccarelli, M.
    D'Avino, A.
    Mondi, A.
    Borghetti, A.
    Fantoni, M.
    Cauda, R.
    Di Giambenedetto, S.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2012, 15 : 29 - 29
  • [40] An evaluation of elvitegravir plus cobicistat plus tenofovir alafenamide plus emtricitabine as a single-tablet regimen for the treatment of HIV in children and adolescents
    Giacomet, Vania
    Cossu, Maria V.
    Capetti, Amedeo F.
    Zuccotti, GianVincenzo
    Rizzardini, Giuliano
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (03) : 269 - 276